Dear Colleagues,
Join us on 25 January at 17:00 (CET)* for the first of our 2024 webinars.
This webinar will focus on primary efficacy and safety results of the MSF-sponsored endTB trial: a Phase III, open-label, randomized controlled trial comparing five nine-months regimen to a concurrent, evolving standard of care arm for rifampicin-resistant tuberculosis. These results have recently been presented at the Union World Conference on Lung Health in Paris, France (November 2023).
*Please note that from 2024 webinars will be held every last Thursday of the month at 17:00 CET (instead of 16:00 CET).
Join us on Zoom!
Link: https://us06web.zoom.us/j/89952592394?pwd=HWIWqDarvou2UQs8HlaxBZ3syimNgU.1
Meeting ID: 899 5259 2394
Passcode: 069348
Our speakers are:
Maelenn Gouillou is a biostatistician in Epicentre, a Médecins sans Frontières (MSF) satellite focused on epidemiology and research. Currently, she is the operational statistician for the endTB trials. She has international experience in the analysis of epidemiological studies and clinical trials.
Lorenzo Guglielmetti is an infectious diseases physician and epidemiologist with a strong focus on clinical research to improve the treatment of drug-resistant TB. He is a clinician and researcher at the National Reference Center for Mycobacteria (Pitié-Salpêtrière Hospital, Paris, France) and director of the endTB project for Médecins Sans Frontières. He is Chair of the ESCMID Study Group on Mycobacterial Infections (ESGMYC) and part of the Steering Committee of the TBnet.
Chairs of the webinar:
Liga Kuksa is a pulmonologist and the chair of TBnet. She is the Head of the Multidrug-Resistant TB Department, TB and Lung Disease Center, Riga East University Hospital and also the head of the Latvian WHO Collaborating Center for Research and Training in Management of Multidrug-Resistant Tuberculosis. Her work is focused on MDR-TB management, as well as research and training in the field of TB at the national and international level.
Simone Tunesi is an infectious diseases physician focused on TB clinical management. Currently working in Alessandria, Italy, with past experiences in France, including a Sanatorium, and in a rural health service in Senegal. His research works include clinical management of DR TB, coadministration of DAAs and second line TB drugs and the role of T-SPOT in lymphadenitis diagnosis. Simone is a member of the Steering Committee in charge of Clinical Tuberculosis area.
